ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,653Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 537

$1.33M Total Retail Price of All Prescriptions

Rank: 4 out of 537

423 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 2,772 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$153 was the average price of a prescription from this provider, compared to $126 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 525 162 1 3
CALCIUM ACETATE 486 161 10 2 6
RENVELA 399 110 3 4
AMLODIPINE BESYLATE 382 118 4 1
SENSIPAR 331 111 5 5
SIMVASTATIN 251 107 6 12
GABAPENTIN 245 91 7 25
NIFEDIPINE ER 230 43 8 16
METOPROLOL TARTRATE 217 54 9 9
ZOLPIDEM TARTRATE 188 40 10 27
LEVOTHYROXINE SODIUM 167 68 11 18
LABETALOL HCL 166 32 12 36
CLONIDINE HCL 158 16 13 10
HYDRALAZINE HCL 133 43 14 11
LANTUS 130 25 15 44
HYDROCODONE-ACETAMINOPHEN 119 27 S3 16 8
PREDNISONE 118 51 17 21
NEXIUM 113 29 18 23
CARVEDILOL 113 41 18 7
PANTOPRAZOLE SODIUM 112 32 20 33
QUINAPRIL HCL 106 18 21 155
INSULIN SYRINGE 100 14 22 47
DIOVAN 95 43 23 24
METOCLOPRAMIDE HCL 87 24 24 62
CLOPIDOGREL 87 25 24 52
PROMETHAZINE HCL 83 0 R 26 88
ROPINIROLE HCL 83 23 26 107
ATORVASTATIN CALCIUM 80 30 28 26
BUMETANIDE 78 58 29 48
ISOSORBIDE MONONITRATE ER 76 27 30 54
NIFEDICAL XL 74 21 31 56
TRICOR 71 27 32 104
FUROSEMIDE 69 56 33 2
HUMULIN N 67 17 34 149
CITALOPRAM HBR 67 31 34 68
LOSARTAN POTASSIUM 65 18 36 15
MINOXIDIL 62 0 37 34
MIDODRINE HCL 61 17 38 90
METOPROLOL SUCCINATE 58 0 39 20
SERTRALINE HCL 58 0 39 53
PLAVIX 58 14 39 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 20 42 22
NOVOLIN N 55 13 43 199
PRAVASTATIN SODIUM 53 20 44 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.